PN

Pui Yee Ng

VD Valo Early Discovery: 6 patents #1 of 18Top 6%
FT Forma Therapeutics: 2 patents #18 of 50Top 40%
GL Glaxosmithkline: 1 patents #1 of 20Top 5%
HI H. Lee Moffitt Cancer Center And Research Institute: 1 patents #20 of 101Top 20%
📍 Lexington, MA: #14 of 460 inventorsTop 4%
🗺 Massachusetts: #194 of 14,474 inventorsTop 2%
Overall (2020): #10,679 of 565,922Top 2%
9
Patents 2020

Issued Patents 2020

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
10874649 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors Xiaozhang Zheng, Mary-Margaret Zablocki 2020-12-29
10870645 Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Aleksandra Rudnitskaya, David R. Lancia, Jr. 2020-12-22
10829460 [6,6] fused bicyclic HDAC8 inhibitors Xiaozhang Zheng, Jennifer R. Thomason, Mary-Margaret Zablocki, Bingsong Han, Nicholas Barczak +4 more 2020-11-10
10829461 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2020-11-10
10829462 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2020-11-10
10822316 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2020-11-03
10590135 Substituted bridged urea analogs as sirtuin modulators Charles A. Blum, Richard D. Caldwell, Rebecca Casaubon, Jeremy S. Disch, Ryan Michael Fox +6 more 2020-03-17
10555935 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors Xiaozhang Zheng, Mary-Margaret Zablocki 2020-02-11
10538496 Methods using HDAC11 inhibitors Jennifer Lee, Pearlie Burnette, Srikumar Chellappan, Nicholas Barczak, Jaime Escobedo +8 more 2020-01-21